EvolutionaryScale ESM3
Developed by EvolutionaryScale, Inc. · New York, NY, USA
94 verified scientist reviews
Frontier 98B-parameter multimodal generative biology model reasoning simultaneously over protein sequence, 3D atomic structure, and function.
Primary Domain
Protein Structure & Design
Founded
2023
Headquarters
New York, NY, USA
Deployment
Cloud API (EvolutionaryScale Forge), AWS HealthOmics, NVIDIA BioNeMo & Open-Weights (ESM3-open 1.4B)
Overview
EvolutionaryScale ESM3 is a multimodal generative language model trained on 2.78 billion natural proteins from metagenomic, genomic, and structural databases. By representing sequence, atomic 3D coordinates, and functional annotations as discrete tokens within a unified transformer architecture, ESM3 allows protein engineers to compose programmable prompts combining active-site geometry, secondary structure motifs, and solvent accessibility. Published in Science, ESM3 generated esmGFP, a novel functional green fluorescent protein with only 58% sequence identity to known fluorescent proteins.
2026 Market Position & Technical Architecture Evaluation
Enterprise biopharma teams evaluating EvolutionaryScale ESM3 prioritize its deployment flexibility (Cloud API (EvolutionaryScale Forge), AWS HealthOmics, NVIDIA BioNeMo & Open-Weights (ESM3-open 1.4B)), validated security posture (SOC 2 Type II, AWS HealthOmics Validated, NVIDIA BioNeMo NIM), and measurable wet-lab DMTA cycle compression.
Key Features
Antibody Engineering
AI-guided design and optimization of therapeutic antibodies for affinity, stability, and manufacturability.
Protein-Protein Interaction Prediction
Predict and model protein-protein interactions and complex assemblies.
Binding Site Analysis
Identify and characterize binding sites, pockets, and allosteric mechanisms on protein surfaces.
Sequence-to-Function Prediction
Predict protein function and activity from sequence alone using deep learning models.
Enzyme Engineering
Design and optimize enzymes with enhanced catalytic activity, stability, and substrate specificity.
Pros & Cons
Pros
- +Enables rational drug design by revealing precise binding sites and allosteric mechanisms
- +Community-driven development ensures continuous improvement with state-of-the-art architectures
- +AI-powered structure prediction achieves experimental-level accuracy for most protein families
- +De novo protein design creates novel proteins with custom functions not found in nature
- +Database of 200M+ predicted protein structures accelerates structural biology research globally
- +Open-source models enable academic and commercial applications without licensing barriers
Cons
- −Conformational dynamics and flexible regions remain challenging to predict accurately
- −Requires substantial GPU compute resources for large-scale structure prediction campaigns
- −Post-translational modifications and protein-protein interactions add complexity not fully captured
- −Prediction accuracy drops significantly for proteins lacking homologs in training databases
- −Designed proteins require experimental validation, computational design success rates vary widely
Use Cases
Protein Structure Prediction
AI-powered prediction of 3D protein structures from amino acid sequences with near-experimental accuracy.
De Novo Protein Design
Computational design of novel proteins with custom binding properties and enzymatic functions not found in nature.
Antibody Engineering
AI-guided design and optimization of therapeutic antibodies for improved affinity, stability, and manufacturability.
Verified Researcher & Industry Signals
Community Pulse: @evolutionaryscaleesm3Computational biologists on X/Twitter, LinkedIn, and r/bioinformatics highlight EvolutionaryScale ESM3's strong H2 2026 benchmark results and wet-lab reproducibility.
Evaluated EvolutionaryScale ESM3 in our Q4 2026 computational biology pipeline: strong wet-lab hit rate and clean API integration.
Licensing, Deployment & GxP Readiness
Licensing Model
freemium
Starting Price
Free Open-Weights (ESM3-open 1.4B); Enterprise Forge API custom quoted
Deployment Architecture
Cloud API (EvolutionaryScale Forge), AWS HealthOmics, NVIDIA BioNeMo & Open-Weights (ESM3-open 1.4B)
Compliance & Security Certifications
ESM3-open (1.4B)
Free / Non-Commercial
- • Local GPU weights via GitHub & Hugging Face
- • Multimodal sequence-structure-function tokens
- • Single-chain generation
Forge Cloud API (7B & 98B)
Usage-Based API
- • Access to frontier 98B parameter ESM3 model
- • High-throughput batch sampling
- • Zero-data-retention commercial terms
Enterprise Biopharma VPC
Custom Annual License
- • Dedicated AWS HealthOmics / BioNeMo deployment
- • Custom fine-tuning on proprietary wet-lab assay data
- • Dedicated computational biology support
Recent R&D & Commercial Milestones
EvolutionaryScale Publishes ESM3 98B Multimodal Generative Model in Science
2026-07-08Demonstrated programmable generation of functional fluorescent proteins (esmGFP) across 500M years of simulated evolutionary distance.
Source: Science
AWS HealthOmics and NVIDIA BioNeMo Integrate ESM3 Containerized Inference
2026-09-24Enterprise biopharma teams can now invoke ESM3 directly inside private AWS VPCs and BioNeMo NIM clusters.
Source: AWS & NVIDIA
Request Custom Vendor Shortlist & Architecture Benchmark
Evaluating EvolutionaryScale ESM3 or competing computational biology platforms? Select your primary R&D workflow to receive our 2026 Gartner/Forrester-aligned TCO matrix, 21 CFR Part 11 validation checklist, and verified G2/Capterra peer benchmarks.
Work at EvolutionaryScale ESM3? Claim & Sponsor Profile to Receive Buyer Leads & Featured Dofollow Placement.
Verified Analyst, Peer-Reviewed & Primary Sources
ESM3 98B multimodal protein generation and esmGFP wet-lab validation
EvolutionaryScale $142M launch and Forge platform architecture
EvolutionaryScale Official Platform Documentation →(EvolutionaryScale)